Lee Aymar Ndounga‐Diakou

Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?

Patricia Raiser, Gudrun Schleiermacher, Marion Gambart et al. · European Journal of Cancer · 2024 · 27 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study

Mathieu Ndounga, Pembé Issamou Mayengué, Prisca Nadine Casimiro et al. · Malaria Journal · 2015 · 26 citations · Full text

Pharmacy, Child Health, Infectious Diseases +10

Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study

Pablo Berlanga, Lee Aymar Ndounga‐Diakou, Isabelle Aerts et al. · JAMA Network Open · 2023 · 20 citations · Full text

Pharmacy, Oncology, Pediatrics +13

Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving <i>ALK</i> -Targeted Therapy

Charles Bobin, Yasmine Iddir, Charlotte Butterworth et al. · Clinical Cancer Research · 2024 · 14 citations · Full text

Medicine, Genetics, Oncology +17